Effects of Cosopt on IOP and on Ocular Diastolic Perfusion Pressure
NCT00796198
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Glaucoma
Interventions
DRUG:
Xalatan+Cosopt
DRUG:
Xalatan
Sponsor
University of Turin, Italy